Validation of Driving Simulator to Blood Alcohol Concentration Standards for Impaired Driving
ALCDrive
1 other identifier
interventional
32
1 country
1
Brief Summary
The proposed study will validate and determine sensitivity of our new driving simulator, created to evaluate driving ability in a related study to show similar driving performance between patients on chronic opioid treatment and a control group. Although the commercial version of the simulator has been validated for certain populations and certain measures, these require re-calibration for our own clinical study. The investigators propose a prospective randomized clinical trial to evaluate driving skills under alcohol consumption using a driving simulator. Two groups of study subjects will be utilized, with the majority (80%) receiving alcohol and placebo at different times. A smaller set of study subjects (20%) will be given placebo on both trials to evaluate learning effects and placebo blinding effectiveness. Each group will take the driving test at three time points: once as a baseline at the beginning of the study, once after the 1st dosing of the placebo and again after dosing two of the alcohol or placebo beverage. This information will allow us to evaluate driving ability under other potentially impairing conditions such as opioid usage.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for phase_3
Started Feb 2008
Longer than P75 for phase_3
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 14, 2007
CompletedFirst Posted
Study publicly available on registry
November 16, 2007
CompletedStudy Start
First participant enrolled
February 1, 2008
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
July 1, 2022
CompletedDecember 14, 2022
December 1, 2022
14.1 years
November 14, 2007
December 12, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Weaving (Standard Deviation of Lateral Deviation)
6 h
Secondary Outcomes (1)
Reaction Time (RT) to unexpected stimuli, and number of accidents
6 h
Study Arms (2)
Alcohol
ACTIVE COMPARATORAlcohol
Placebo
PLACEBO COMPARATOROrange juice
Interventions
Eligibility Criteria
You may qualify if:
- Legal drinking age (=\> 21).
- Moderate alcohol consumption
- Defined as: at least 1 unit per week but less than 20 units per week. (unit = 12 oz. beer or equivalent).
- Current driver's license.
- Subjects can understand and communicate in English.
You may not qualify if:
- Known alcoholic or drug abuser.
- Alcohol naïve.
- Use of medications that may be aggravated (or contraindicated) by alcohol.
- Pregnant or breast feeding.
- Younger than 21 years or older than 80 years.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Rush University Medical Center
Chicago, Illinois, 60612, United States
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Asokumar Buvanendran, MD
Rush University Medical Center
Study Design
- Study Type
- interventional
- Phase
- phase 3
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, OUTCOMES ASSESSOR
- Purpose
- DIAGNOSTIC
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Research Coordinator
Study Record Dates
First Submitted
November 14, 2007
First Posted
November 16, 2007
Study Start
February 1, 2008
Primary Completion
March 1, 2022
Study Completion
July 1, 2022
Last Updated
December 14, 2022
Record last verified: 2022-12